- Home
- BBLG vs MTNB Comparison
BBLG vs MTNB Comparison
Compare BBLG & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBLG | MTNB |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 2.6M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BBLG | MTNB |
|---|---|---|
| Price | $0.48 | $2.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 77.5K | ★ 518.7K |
| Earning Date | 11-13-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.13 | ★ 59.84 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,070,000,000.00 | $119,750.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.43 | $0.15 |
| 52 Week High | $2.79 | $3.05 |
Technical Indicators
Market Signals| Indicator | BBLG | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 28.38 | 85.37 |
| Support Level | $0.43 | $0.56 |
| Resistance Level | $0.59 | N/A |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | 0.01 | 0.30 |
| Stochastic Oscillator | 30.70 | 82.41 |
Price Performance
Historical ComparisonAbout BBLG Bone Biologics Corp
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.